| Financial Year |
March 31 2023 |
| Monetary Funds |
1,664,214,048.14 |
| Held-for-trading Financial Assets |
4,166,311.20 |
| Notes Receivable |
433,481,338.33 |
| Accounts Receivable |
997,773,925.16 |
| Advances to Suppliers |
58,519,951.57 |
| Other Receivables |
31,074,320.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
271,059,259.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,924,935.82 |
| Total Current Assets |
3,650,034,967.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
97,117,509.42 |
| Investment Properties |
19,053,634.43 |
| Fixed Assetes |
2,937,787,178.25 |
| Under-construction Projects |
258,762,847.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
420,871,917.54 |
| R&D expenses |
17,463,779.01 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,174,138.69 |
| Deferred Income Tax Assets |
63,828,151.07 |
| Other Non-Current Assets |
378,778,059.71 |
| Sub-Total of Non-Current Assets |
4,367,098,176.74 |
| Total Assets |
8,017,133,144.14 |
| Short-Term Loans |
4,295,600.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
95,256,731.61 |
| Accounts Payable |
575,607,061.33 |
| Accounts Received In Advance |
1,257,292.69 |
| Employee Compensation Payable |
106,343,133.30 |
| Taxes Payable |
34,665,125.12 |
| Interest Payable |
-- |
| Dividend Payable |
8,798,982.57 |
| Other payables |
302,160,372.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,959,405.66 |
| Other Current Liabilities |
5,397,505.18 |
| Sub-Total of Current Liabilities |
1,367,421,178.76 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,582,452.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
286,411,438.57 |
| Total Liabilities |
1,653,832,617.33 |
| Paid-In Capital(Or Share Stock) |
1,004,847,787.00 |
| Capital Surplus |
1,790,128,633.33 |
| Surplus Reserve |
424,226,307.73 |
| LESS:Treasury Stock |
244,954,936.60 |
| Undistributed Profits |
3,129,202,555.43 |
| Minority Stockholder's Interest |
261,857,464.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,101,443,062.06 |
| Owner's Equity（Stockholder's Equity） |
6,363,300,526.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,017,133,144.14 |
